PROAXON

ProAxon develops sodium channel modulators for the treatment of various central nervous system and non-central nervous system diseases.

#SimilarOrganizations #More

Biotechnology Pharmaceutical

London, England, United Kingdom

United Kingdom

Active

inexia-logo

Inexia aims to develop intranasally administered orexin positive modulators for the treatment of neurological diseases.

thc-pharm-logo

THC Pharm develops drugs & medicinal products for the treatment of multimorbidity, cancer and neurological diseases.